Bioengineers are on the rise
Biosimilar market forecast to 2018
Weekly Pharmacy www.apteka.ua based on MarketsandMarkets: Biosimilars Market Product [...] – Global Forecast to 2018Biosimilars are analogues of drugs of biological origin with a similar, but not identical structure.
The term "biosimilar" is used in EU countries along with definitions such as biosimilar and bioengineer. In the EU, the registration procedure is carried out by the European Medicines Agency.
Due to the impossibility of accurate reproduction of biosimilars, they cannot be a complete copy of the original drug. Therefore, when obtaining a trade license, a full cycle of preclinical and clinical studies must be carried out.
Today, the biosimilar market is actively developing and has good growth prospects. According to the analytical company MarketsandMarkets, by 2018 the biosimilar market may reach 2 billion US dollars. The largest markets for biosimilars are the EU and the USA. The Asia-Pacific region is also a promising market, accounting for 25% of the global biosimilar market. In China and India, by 2018, the market growth (CAGR) will be 30.2 and 29%, which is due to a fairly simple procedure for the admission of biosimilars to the market.
Biosimilars are represented on the world market by three groups: recombinant peptides (calcitonin, glucagon); recombinant non-glycosylated proteins (insulin, somatropin, filgrastim); recombinant glycosylated proteins (erythropoietin, monoclonal antibodies and follitropin).
Recombinant glycosylated proteins account for 40% of the global biosimilar market, which corresponds to $314.2 million. In the coming years, the need for products such as insulin, interferon, which are used in the treatment of diabetes and infectious diseases, will increase. As a result, this segment of biosimilars is expected to grow by 17.5% in the period 2013-2018. According to the forecast, from 2013 to 2018, monoclonal antibodies will be the drivers of market growth, an increase of 40%. It is also worth noting that biosimilars, which are used in the treatment of oncological diseases, occupy 25% of this market and are one of the most promising and fast-growing segments.
Portal "Eternal youth" http://vechnayamolodost.ru13.01.2015